BIM
NVO

Brentview Investment Management’s Novo Nordisk NVO Stock Holding History

Brentview Investment Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.7K Sell
1,579
-755
-32% -$32.4K 0.03% 46
2026
Q1 		$85.8K Hold
2,334
– – 0.04% 44
2025
Q4 		$119K Hold
2,334
– – 0.05% 43
2025
Q3 		$130K Hold
2,334
– – 0.06% 42
2025
Q2 		$161K Hold
2,334
– – 0.08% 42
2025
Q1 		$162K Hold
2,334
– – 0.09% 42
2024
Q4 		$201K Buy
+2,334
New +$252K 0.11% 40

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Brentview Investment Management's NVO Position: Q2 2026 in Review

Brentview Investment Management reduced its Novo Nordisk (NVO) stake by 32% in Q2 2026, selling an estimated $32.4K and leaving 1,579 shares worth $75.7K. The position accounts for 0.03% of the portfolio, ranked #46.

Brentview Investment Management first reported a position in NVO in Q4 2024 and has held it in 7 quarters since. The position peaked at $201K in Q4 2024. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Brentview Investment Management held 1,579 shares of Novo Nordisk worth $75.7K as of Q2 2026.
  • Brentview Investment Management sold 755 Novo Nordisk shares in Q2 2026, an estimated $32.4K.
  • Novo Nordisk made up 0.03% of Brentview Investment Management's portfolio in Q2 2026, its #46 holding.
  • Brentview Investment Management first reported a position in Novo Nordisk in Q4 2024 and has held it in 7 quarters since.
  • Brentview Investment Management's Novo Nordisk position peaked at $201K in Q4 2024.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Brentview Investment Management's 13F filing for Q2 2026, filed 30 Jul 2026.